Research Opportunities

Free treatment may be available if you are able to access research studies being conducted either in your community or elsewhere in the country. Some studies, particularly those at the National Institute of Mental Health, are able to assist with travel costs. The following websites offer information about ongoing research studies for children with mood disorders.

www.nimh.nih.gov/studies/index.cfm National Institute of Mental Health

www.thebalancedmind.org The Balanced Mind Foundation (formerly known as www.bpkids.org or www.cabf.org)

http://www.dbsalliance.org/site/PageServer?pagename=research_researchtrialslanding Depression and Bipolar Suppport Alliance

http://www.jbrf.org/research/index.html Juvenile Bipolar Research Foundation

Studies Being Conducted at The Ohio State University/Nationwide Children’s Hospital (OSU/NCH) Childhood Mood Disorders Program-Columbus, Ohio

Impact of MF-PEP in Community Settings

Children who attend MF-PEP groups being run at the NCH Behavioral Health Clinics (East-Reynoldsburg, North-Westerville, East Central-Downtown) have the opportunity to participate in a study to determine the impact of MF-PEP when provided in usual-care conditions. This study is being conducted as part of Heather MacPherson, MA’s doctoral dissertation. Ms. MacPherson is supervised by Dr. Mary Fristad. If interested in participating in MF-PEP, please contact the main referral line at NCH at 614-355-8080 and ask to participate in a Child MF-PEP group. Note: While treatment is not free of charge in this study, families are compensated for completion of evaluation materials.

Impact of Omega-3 Fatty Acids and IF-PEP on Children with Depression

Children with dysthymic disorder and/or major depressive disorder are invited with their parents to participate in a 12-week trial. Half of the children will receive omega3 fatty acids, half will receive placebo. Neither the primary study investigators nor the family will know what the child is receiving. Half the children and parents will participate in IF-PEP, half the families will receive active monitoring (i.e., multiple assessments). For more information, please contact Kayden Healy, BA at 614-293-4908.

Impact of Omega-3 Fatty Acids and IF-PEP on Children with BP-NOS/CYC

Children with bipolar disorder- not otherwise specified (BP-NOS) or cyclothymic disorder (CYC) are invited with their parents to participate in a 12-week trial. Half of the children will receive omega3 fatty acids, half will receive placebo. Neither the primary study investigators nor the family will know what the child is receiving. Half the children and parents will participate in IF-PEP, half the families will receive active monitoring (i.e., multiple assessments). For more information, please contact Kayden Healy, BA at 614-293-4908.

Program Evaluation- Adaptation of MF-PEP for Adolescents

We are in the process of adapting MF-PEP for adolescents with mood disorders. Groups are scheduled to begin January 9, 2012. If you are interested in enrolling a teenager and his/her parent(s) in MF-PEP, please contact the main referral line for NCH at 614-355-8080 and ask to participate in the Teen MF-PEP group. Note: As this is a program evaluation of a new clinical service, compensation is not available to families.

Program Evaluation- Adaptation of MF-PEP for Children with Autism Spectrum Disorders (ASD)

We are currently conducting a program evaluation of the newly adapted MF-PEP for children with ASD being treated at the NCH Center for Autism Spectrum Disorders at the Child Development Center in Westerville. Information gained from this program evaluation will be used to further modify, then evaluate MF-PEP in this population. If you are interested in enrolling a child with ASD and his/her parent(s) in MF-PEP, please contact an Autism Resource Coordinator at 614-355-8315. Note: As this is a program evaluation of an existing clinical service, compensation is not available to families.

Other Ongoing Studies of PEP

Children and their parents from Rural Kansas are invited to participate in a pilot efficacy evaluation of IF-PEP delivered via tele-health services. For more information, please contact Dr. Nicole Klaus at 316-293-2647 or nklaus@kumc.edu

Comments are closed.